Live Breaking News & Updates on Cardiovascular Business Development

Stay updated with breaking news from Cardiovascular business development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MCRA Expands its Cardiovascular Division, Hiring Fernando Aguel, Former Assistant Division Director, FDA Circulatory Support Devices


MCRA Expands its Cardiovascular Division, Hiring Fernando Aguel, Former Assistant Division Director, FDA Circulatory Support Devices
News provided by
Share this article
Share this article
WASHINGTON, May 20, 2021 /PRNewswire/ MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating US and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce the hiring of Fernando Aguel as Vice President, Heart Failure & Circulatory Support Regulatory Affairs. Fernando previously served as U.S. Food and Drug Administration (FDA) Assistant Division Director, Circulatory Support Devices Team. MCRA s Cardio division continues to expand its expertise across all product areas in the cardiovascular space to provide clients with expert regulatory guidance, clinical study design and clinical trial execution.  ....

New York , United States , Anne Obrien , Michael John , Heart Failure Circulatory Support Regulatory Affairs , Drug Administration , Circulatory Support Devices Team , Viscogliosi Brothers , International Regulatory , Cardiovascular Business Development , Radiological Health , Clinical Research Organization , Division Of Compounded Drugs , Head Of Cardiovascular Regulatory Affairs , Clinical Research , Office Of Device Evaluation , Healthcare Compliance , Quality Assurance , Fernando Aguel , Vice President , Heart Failure , Circulatory Support Regulatory , Assistant Division Director , Circulatory Support Devices , Compounded Drugs , Device Evaluation ,

MCRA Hires Cardiovascular Industry Leader Dr. Hans-Peter Stoll to its CRO Management Team


Share this article
Share this article
WASHINGTON, March 11, 2021 /PRNewswire/ MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) dedicated to integrating US and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce the hiring of Dr. Hans-Peter Stoll, an interventional cardiologist. Dr. Stoll formerly served as Chief Medical Officer at Biosensors International where he led the clinical affairs group and provided medical strategic leadership to executive management. Additional cardiovascular device industry experience includes roles as Chief Medical Officer Cardiology at GE Healthcare and as Worldwide Vice President Clinical Research at Cordis, a Johnson & Johnson company. ....

New York , United States , Anne Obrien , Michael John , Hans Peter Stoll , Marc Viscogliosi , Saarland University , Viscogliosi Brothers , International Clinical Affairs , International Regulatory , Cardiovascular Business Development , Cardiovascular Regulatory Affairs , Cardiovascular Research , Clinical Research Organization , Clinical Research , Clinical Research At Cordis , Biosensors International , Ge Healthcare , Healthcare Compliance , Quality Assurance , Chief Medical Officer , Chief Medical Officer Cardiology , Worldwide Vice President Clinical Research , Vice President , New York City , Health Care Amp Hospitals ,